An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004
- 31 December 2005
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 53 (4) , 247-256
- https://doi.org/10.1016/j.diagmicrobio.2005.10.006
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Antibiotic policies in Central Eastern EuropeInternational Journal of Antimicrobial Agents, 2004
- Epidemiology and control of antibiotic resistance in the intensive care unitCurrent Opinion in Infectious Diseases, 2004
- Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 -Lactamases in New York CityClinical Infectious Diseases, 2004
- The use and resistance to antibiotics in the communityInternational Journal of Antimicrobial Agents, 2003
- Surveillance of antimicrobial resistance — what, how and whither?Clinical Microbiology & Infection, 2001
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- New -Lactamases in Gram-Negative Bacteria: Diversity and Impact on the Selection of Antimicrobial TherapyClinical Infectious Diseases, 2001
- Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in TurkeyJournal of Antimicrobial Chemotherapy, 2000
- Meropenem: clinical response in relation to in vitro susceptibilityClinical Microbiology & Infection, 2000